Certara Inc
CERT
Market Cap$1.71B
Close$
$10.39
4.4% downside
Current Fair Value
4.4% downsideOvervalued by 4.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.71 Billion |
|---|---|
| Enterprise Value | $1.62 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.08 |
| Beta | 1.45 |
| Outstanding Shares | 160,996,258 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -646.44 |
|---|---|
| PEG | 321.16 |
| Price to Sales | 5.43 |
| Price to Book Ratio | 1.81 |
| Enterprise Value to Revenue | 4.1 |
| Enterprise Value to EBIT | -547.7 |
| Enterprise Value to Net Income | -616 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Certara Inc
300 employeesCertara optimizes R&D productivity, commercial value and patient outcomes through its unique portfolio of model-informed drug development, regulatory science, and market access solutions. In fact, 90+% of all novel drugs approved by the ...